Press Release
AVILAR THERAPEUTICS INCREASES FINANCING TO $75 MILLION TO ADVANCE PIPELINE OF NOVEL EXTRACELLULAR PROTEIN DEGRADERS
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009
Aspen Neuroscience Inks $40 Million Debt Deal with Silicon Valley Bank
Multi-omics Startup Pleno Inc. Continues to Strengthen its Board of Directors
Multi-omics Startup Pleno Inc. Expands Leadership Team to Accelerate Development of its Novel Hypercoding Technology
CMC Expert Kim Raineri Joins Aspen Neuroscience as Chief Technology Officer
Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital
Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund